Malaysia · Delayed Price · Currency is MYR KLSE:DCHCARE Statistics
Total Valuation
KLSE:DCHCARE has a market cap or net worth of MYR 124.54 million. The enterprise value is 132.79 million.
| Market Cap | 124.54M |
| Enterprise Value | 132.79M |
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:DCHCARE has 996.30 million shares outstanding. The number of shares has increased by 12.10% in one year.
| Current Share Class | 996.30M |
| Shares Outstanding | 996.30M |
| Shares Change (YoY) | +12.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.59% |
| Owned by Institutions (%) | 0.30% |
| Float | 212.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.54 |
| PB Ratio | 2.76 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | 17.27 |
| P/OCF Ratio | 8.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.72, with an EV/FCF ratio of 18.42.
| EV / Earnings | -54.20 |
| EV / Sales | 1.64 |
| EV / EBITDA | 9.72 |
| EV / EBIT | n/a |
| EV / FCF | 18.42 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.12 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | 4.50 |
| Interest Coverage | -0.46 |
Financial Efficiency
Return on equity (ROE) is -5.28% and return on invested capital (ROIC) is -1.40%.
| Return on Equity (ROE) | -5.28% |
| Return on Assets (ROA) | -0.45% |
| Return on Invested Capital (ROIC) | -1.40% |
| Return on Capital Employed (ROCE) | -1.05% |
| Weighted Average Cost of Capital (WACC) | 2.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.80 |
| Inventory Turnover | 9.73 |
Taxes
| Income Tax | -7,807 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.27% in the last 52 weeks. The beta is -0.33, so KLSE:DCHCARE's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | -27.27% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 54.90 |
| Average Volume (20 Days) | 924,470 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:DCHCARE had revenue of MYR 80.87 million and -2.45 million in losses. Loss per share was -0.00.
| Revenue | 80.87M |
| Gross Profit | 41.67M |
| Operating Income | -732,735 |
| Pretax Income | -2.46M |
| Net Income | -2.45M |
| EBITDA | 6.41M |
| EBIT | -732,735 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 24.19 million in cash and 32.44 million in debt, with a net cash position of -8.25 million or -0.01 per share.
| Cash & Cash Equivalents | 24.19M |
| Total Debt | 32.44M |
| Net Cash | -8.25M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 45.16M |
| Book Value Per Share | 0.05 |
| Working Capital | 4.01M |
Cash Flow
In the last 12 months, operating cash flow was 13.85 million and capital expenditures -6.64 million, giving a free cash flow of 7.21 million.
| Operating Cash Flow | 13.85M |
| Capital Expenditures | -6.64M |
| Free Cash Flow | 7.21M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 51.53%, with operating and profit margins of -0.91% and -3.03%.
| Gross Margin | 51.53% |
| Operating Margin | -0.91% |
| Pretax Margin | -3.04% |
| Profit Margin | -3.03% |
| EBITDA Margin | 7.93% |
| EBIT Margin | -0.91% |
| FCF Margin | 8.92% |
Dividends & Yields
KLSE:DCHCARE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.10% |
| Shareholder Yield | -12.10% |
| Earnings Yield | -1.97% |
| FCF Yield | 5.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:DCHCARE has an Altman Z-Score of 2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | 3 |